Black seed oil nanoemulsion containing albendazole against protoscoleces of Echinococcus granulosus: An in vivo study

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 60

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-28-6_008

تاریخ نمایه سازی: 26 فروردین 1404

چکیده مقاله:

Objective(s): Hydatid cysts are typically treated with albendazole. Nevertheless, this drug has side effects and limited bioavailability. In this study, we aimed to explore a nanoemulsion of black seed oil to enhance the therapeutic efficacy of albendazole in mice with hydatid cysts. Materials and Methods: The size of the prepared nanoemulsions was characterized using a Zetasizer analyzer. Additionally, the stability of the nanoemulsions was assessed after ۴۵ days. MTT assay was used to compare the cytotoxicity of free albendazole, nanoemulsion containing albendazole, and nanoemulsion without albendazole. Furthermore, infected mice were treated with these preparations, euthanized, and subjected to autopsy examination. Cysts obtained from mice were examined for histopathological features. Results: ALB-NE (albendazole-loaded nanoemulsion) DLS results were obtained from black seed oil. Freshly prepared ALB-NE showed (d۵۰ = ۱۷۰ nm), PDI: ۰.۳۲۳, ALB-NE after ۴۵ days storage at ۲۵ ºC were (d۵۰ = ۹۲.۴ nm), and ALB-NE after ۴۵ days storage at ۴۵ ºC revealed (d۵۰ = ۱۱۸ nm). The cytotoxicity of albendazole was reduced when loaded into the nanoemulsion. Moreover, the group treated with nanoemulsion containing albendazole showed a significant decrease in size and number of cysts compared to those receiving free albendazole or nanoemulsion without the drug. Additionally, after ۶۰ days, the nanoemulsion containing albendazole showed ۱۰۰% survival, while the survival rate was ۵۰% for free albendazole, ۷۵% for nanoemulsion without albendazole, and ۳۷.۵% for PBS. Conclusion: The nanoemulsion containing albendazole can be a promising treatment for hydatid cysts.

نویسندگان

Fatemeh Oroojaian

Department of Advanced Technologies, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran

Tahereh Mohammadzadeh

Department of Parasitology and Mycology, School of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

Ailin Ebrahimzadeh

Department of Advanced Technologies, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran

Peiman Aleshiekh

Natural Products and Medicinal Plants Research Center North Khorasan University of Medical Sciences, Bojnurd, Iran

Reza Shafiei

Vector-borne Diseases Research Center North Khorasan University of Medical Sciences, Bojnurd, Iran

Amir Amani

Department of Advanced Technologies, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Shafiei R, Ghatee M, Jafarzadeh F, Javanshir Z, Karamian M. ...
  • Zhou T, Xu Y, Gong Y, Yu M, Xu E, ...
  • Firouzeh N, Eslaminejad T, Shafiei R, Faridi A, Fasihi Harandi ...
  • Shafiei R, Mohajerzadeh MS, Masomi HFA, Tavakoli M, Turki H, ...
  • Moro P, Schantz PM. Echinococcosis: A review. Int J Infect ...
  • Velasco-Tirado V, Alonso-Sardón M, Lopez-Bernus A, Romero-Alegría Á, Burguillo FJ, ...
  • Siracusano A, Teggi A, Ortona E. Human cystic echinococcosis: old ...
  • Chai J-Y, Jung B-K, Hong S-J. Albendazole and mebendazole as ...
  • Falagas ME, Bliziotis IA. Albendazole for the treatment of human ...
  • Venkatesan P. Albendazole. J Antimicrob Chemother ۱۹۹۸; ۴۱:۱۴۵-۱۴۷ ...
  • Dehkordi AB, Sanei B, Yousefi M, Sharafi SM, Safarnezhad F, ...
  • Hong S-T. Albendazole and praziquantel: Review and safety monitoring in ...
  • Azizi M, Chizzola R, Ghani A, Oroojalian F. Composition at ...
  • Azizi M, Tavana M, Farsi M, Oroojalian F. Yield performance ...
  • Movahedi R, Razmjoue D, Bahmani M, Lysiuk R, Oroojalian F. ...
  • Akhlaghi M, Taebpour M, Sharafaldini M, Javani O, Haghiralsadat BF, ...
  • Yazdi AM, Hosseini A, Gheibihayat SM, Beygi M, Haghiralsadat BF, ...
  • Shoorgashti R, Shahrzad H, Nowroozi S, Ghadamgahi B, Mehrara R, ...
  • Gholami Z, Dadmehr M, Jelodar NB, Hosseini M, Parizi AP. ...
  • Yousefpoor Y, Esnaashari SS, Baharifar H, Mehrabi M, Amani A. ...
  • Divanbeigi N, Yousefian M, Etemad L, Azizi M, Ebrahimzadeh A, ...
  • Maghbool M, Khosravi T, Vojdani S, Chaijan MR, Esmaeili F, ...
  • Valizadeh A, Shirzad M, Pourmand MR, Farahmandfar M, Sereshti H, ...
  • Ammar HO, Salama H, Ghorab M, Mahmoud A. Nanoemulsion as ...
  • Amani A, York P, Chrystyn H, Clark BJ. Evaluation of ...
  • Khani S, Keyhanfar F, Amani A. Design and evaluation of ...
  • Chhabra G, Chuttani K, Mishra AK, Pathak K. Design and ...
  • Veerareddy PR, Poluri K, Sistla R, Chaganty S, Vennishetty V. ...
  • Azami SJ, Teimouri A, Keshavarz H, Amani A, Esmaeili F, ...
  • Azami SJ, Amani A, Keshavarz H, Najafi-Taher R, Mohebali M, ...
  • Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, ...
  • Pishavar E, Oroojalian F, Ramezani M, Hashemi M. Cholesterol‐conjugated PEGylated ...
  • Pishavar E, Oroojalian F, Salmasi Z, Hashemi E, Hashemi M. ...
  • Oroojalian F, Rezayan AH, Shier WT, Abnous K, Ramezani M. ...
  • Oroojalian F, Rezayan AH, Mehrnejad F, Nia AH, Shier WT, ...
  • Ahmadnia S, Moazeni M, Mohammadi-Samani S. Hydatid cyst formation in ...
  • Rafiei A, Asgarian F, Rahdar M, Jelowdar A, Sabaghan M. ...
  • Faraji AH, Wipf P. Nanoparticles in cellular drug delivery. Bioorg ...
  • Petersen JS, Baird SK. Treatment of breast and colon cancer ...
  • Hashemi-Hafshejani S, Amani A, Azami SJ, Valian HK, Mohebali M, ...
  • Teimouri A, Jafarpour Azami S, Hashemi Hafshejani S, Ghanimatdan M, ...
  • Stuchlík M, Zak S. Lipid-based vehicle for oral drug delivery. ...
  • Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral ...
  • Shaker DS, Ishak RA, Ghoneim A, Elhuoni MA. Nanoemulsion: A ...
  • Aburahma MH, El-Laithy HM, Hamza YE-S. Oral bioavailability enhancement of ...
  • نمایش کامل مراجع